News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nelson Sonja
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4
| Nelson Sonja (CFO) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 389,000 options to buy
@ $0 |
|
| 04/28/2023 |
4
| Nelson Sonja (Chief Fin. & Operating Officer) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 1,000,000 shares
@ $0 |
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| Nelson Sonja (Director) has filed a Form 4 on Motus GI Holdings, Inc.|
Txns:
| Granted 82,500 shares
@ $0 |
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Nelson Sonja (CFO) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Paid exercise price by delivering 3,458 shares
@ $11.18, valued at
$38.7k
Exercised 10,000 restricted stock units
@ $0 |
|
| 03/24/2020 |
4
| Nelson Sonja (CFO) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Paid exercise price by delivering 6,132 shares
@ $2.82, valued at
$17.3k
Exercised 15,000 restricted stock units
@ $0 |
|
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/29/2018 |
4
| Nelson Sonja (CFO) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Granted 200,000 options to buy
@ $3.07, valued at
$614k
|
|
| 08/03/2018 |
4
| Nelson Sonja (CFO) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Granted 40,000 restricted stock units
@ $0 |
|
| 03/26/2018 |
4
| Nelson Sonja (Chief Accounting Officer) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Exercised 15,000 restricted stock units
@ $0 |
|
|
|